Jumpcode Genomics, founded with a mission to revolutionize next-generation sequencing (NGS) technology, aims to enhance research capabilities in fields such as infectious disease, oncology, and consumer genomics. Their core vision is to improve sensitivity, reduce costs, simplify workflows, and eliminate bias in sequencing processes. The company offers a range of products including the Single Cell RNA Boost Kit, DepleteX® Human DNA Depletion Kit, and CRISPRclean RNA Prep, which are designed to optimize single-cell analysis, microbiome studies, and whole transcriptome profiling.

Notable figures affiliated with Jumpcode Genomics include leading researchers and scientists who have contributed to advancements in genomic technologies. The company has secured investments from prominent venture capital firms, bolstering its capacity for innovation. Key achievements include the development and patenting of their CRISPRClean technology, which has been widely adopted by researchers globally. Jumpcode Genomics has significantly impacted the field of genomics by providing tools that enhance the accuracy and efficiency of NGS, thereby advancing scientific understanding and potential therapeutic applications.